Interaction between azathioprine and aminosalicylates: An in vivo study in patients with Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 1, 2002, Pages 79-85

  Dewit, O ^a   Vanheuverzwyn, R ^a   Desager, J P ^a   Horsmans, Y ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; DRUG METABOLITE; MESALAZINE; METHYLTRANSFERASE; SALAZOSULFAPYRIDINE; TIOGUANINE;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; BLOOD CELL COUNT; BONE MARROW DEPRESSION; CLINICAL ARTICLE; CROHN DISEASE; DRUG BLOOD LEVEL; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; BIOLOGICAL MARKERS; CROHN DISEASE; DRUG INTERACTIONS; FEMALE; GUANINE NUCLEOTIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MESALAMINE; METHYLTRANSFERASES; MIDDLE AGED; SULFASALAZINE; THIONUCLEOTIDES;

EID: 0036161781     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01156.x     Document Type: Article

References (23)

1. Azathioprine and 6-mercaptopurine in Crohn's disease: A meta-analysis
2. Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatment
3. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
4. 6-Mercaptopurine in the management of inflammatory bowel disease: Short- and long-term toxicity
5. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
6. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia
7. Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase
8. Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism
9. Pharmacogenetics of acute azathioprine toxicity: Relationship to thiopurine methyltransferase genetic polymorphism
10. Clinical pharmacokinetics of allopurinol
11. Clinical implications of thiopurine methyltransferase. Optimization of drug dosage and potential drug interactions
12. Sulphasalazine inhibition of thiopurine methyltransferase: Possible mechanism for interaction with 6-mercaptopurine and azathioprine
13. Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug interaction
14. Balsalazide and azathioprine or 6-mercaptopurine: Evidence for a potentially serious drug interaction
15. Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine
16. Warfarin and azathioprine: A drug interaction does exist
17. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: Quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample
18. Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties
19. Validation of a LC method for the determination of 5-aminosalicylic acid and its metabolite in plasma and urine
20. Systemic availability of 5-aminosalicylic acid: Comparison of delayed release and an azo-bond preparation
21. Simultaneous determination of 5-aminosalicylic acid and 5-acetylaminosalicylic acid by high performance liquid chromatography
22. Adverse reactions during salicylazosulphapyridine therapy and the relation with drug metabolism and acetylator phenotype
23. Clinical pharmacokinetics of sulphasalazine